SCHEMBL10691872

SCHEMBL10691872

C/C=C(/C(=O)OCC)c1csc(NC(C)=O)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.56
CYP2C19 P33261 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.55
SMN1; SMN2 Q16637 6/20 0.53
RAB9A P51151 4/20 0.51
NPC1 O15118 3/20 0.51
GAA P10253 3/20 0.51
TDP1 Q9NUW8 1/20 0.49
MAPT P10636 2/20 0.48
HSP90AA1 P07900 2/20 0.48
MAPK1 P28482 1/20 0.48
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 2/20 0.47
LMNA P02545 2/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
EGFR P00533 1/20 0.46
ALDH1A1 P00352 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10428930 1.00 CYP1A2 (0.56) CYP1A2CYP2C19L3MBTL1SMN1; SMN2RAB9A
SCHEMBL10691329 1.00 CYP1A2 (0.56) CYP1A2CYP2C19L3MBTL1SMN1; SMN2RAB9A
SCHEMBL4871149 0.85 CYP1A2 (0.76) CYP1A2CYP2C19L3MBTL1SMN1; SMN2RAB9A
SCHEMBL10995722 0.84 CYP1A2 (0.51) CYP1A2CYP2C19SMN1; SMN2RAB9ANPC1
SCHEMBL10428684 0.82 L3MBTL1 (0.55) CYP1A2CYP2C19L3MBTL1SMN1; SMN2RAB9A
SCHEMBL10694480 0.80 L3MBTL1 (0.69) CYP1A2CYP2C19L3MBTL1SMN1; SMN2RAB9A
SCHEMBL10694485 0.80 L3MBTL1 (0.69) CYP1A2CYP2C19L3MBTL1SMN1; SMN2RAB9A
SCHEMBL7107465 0.78 MAPT (0.68) CYP1A2CYP2C19L3MBTL1SMN1; SMN2RAB9A
SCHEMBL11184434 0.78 MAPT (0.68) CYP1A2CYP2C19L3MBTL1SMN1; SMN2RAB9A
SCHEMBL7107470 0.78 MAPT (0.68) CYP1A2CYP2C19L3MBTL1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4782162-A Novel intermediates for the synthesis of cephalosporins BAYER AKTIENGESELLSCHAFT (DE) 1988-11-01 US disclosed
EP-0161617-A2 Intermediates and process for the preparation of intermediates in the synthesis of cephalosporins BAYER AG (DE) 1985-11-21 EP disclosed